Announcements from Department of Health

Please note the following announcements from Department of Health:

• Valacyclovir-containing products - Assessing the potential risk of drug reaction with eosinophilia and systemic symptoms (DRESS) 
• Attention to Transplanting of Regulated Products under the Human Organ Transplant Ordinance (Cap. 465) (Letter | List of currently exempted products as at 23 May 2022)
• Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia